DCGI issues notice to Serum Institute over AstraZeneca-Oxford COVID-19 vaccine trial suspension Read more
Success of indigenous COVID-19 vaccines will make access easy and affordable in India: GlobalData Read more
SII, Gavi and BMGF collaborate for COVID-19 vaccines, SII to price per vaccine dose at Rs 225 Read more
Serum Institute of India gets DCGI nod for phase 2 and 3 human trials of Oxford vaccine candidate Read more
COVID-19 panel recommends DCGI to permit SII to conduct human trials of Oxford vaccine candidate Read more